[1]
|
Fama’, F., Sindoni, A., Sun, H., Kim, H.Y., Geraci, G., Colonna, M.R., Mazzeo, C., Brenta, G., Galeano, M., Benvenga, S. and Dionigi, G. (2022) Development of Histologically Verified Thyroid Diseases in Women Operated for Breast Cancer: A Review of the Literature and a Case Series. Journal of Clinical Medicine, 11, Article No. 3154.
https://doi.org/10.3390/jcm11113154
|
[2]
|
Turken, O., NarIn, Y., DemIrbas, S., Onde, M.E., Sayan, O., KandemIr, E.G., YaylacI, M. and Ozturk, A. (2003) Breast Cancer in Association with Thyroid Disorders. Breast Cancer Research, 5, Article No. R110.
https://doi.org/10.1186/bcr609
|
[3]
|
Zervoudis, S., Iatrakis, G., Markja, A., Tsatsaris, G., Bothou, A., von Tempelhoff, G.F., Balafouta, M. and Tsikouras, P. (2021) Risk Factors of Synchronous Breast and Thyroid Cancer: A Controlled Multicenter Study and Review of the Literature. Materia Socio-Medica, 33, 298-303. https://doi.org/10.5455/msm.2021.33.298-303
|
[4]
|
Dobrinja, C., Scomersi, S., Giudici, F., Vallon, G., Lanzaro, A., Troian, M., Bonazza, D., Romano, A., Zanconati, F., de Manzini, N. and Bortul, M. (2019) Association between Benign Thyroid Disease and Breast Cancer: A Single Center Experience. BMC Endocrine Disorders, 19, Article No. 104. https://doi.org/10.1186/s12902-019-0426-8
|
[5]
|
Bach, L., Kostev, K., Schiffmann, L. and Kalder, M. (2020) As-sociation between Thyroid Gland Diseases and Breast Cancer: A Case-Control Study. Breast Cancer Research and Treatment, 182, 207-213.
https://doi.org/10.1007/s10549-020-05675-6
|
[6]
|
Peixoto, M.S., de Vasconcelos e Souza, A., Andrade, I.S., de Carvalho el Giusbi, C., Coelho Faria, C., Hecht, F., Miranda-Alves, L., Ferreira, A.C.F., Carvalho, D.P. and Fortunato, R.S. (2021) Hypothyroidism Induces Oxidative Stress and DNA Damage in Breast. Endocrine-Related Cancer, 28, 505-519. https://doi.org/10.1530/ERC-21-0010
|
[7]
|
Jomova, K. and Valko, M. (2011) Advances in Metal-Induced Oxidative Stress and Human Disease. Toxicology, 283, 65-87. https://doi.org/10.1016/j.tox.2011.03.001
|
[8]
|
Valko, M., Rhodes, C.J., Moncol, J., Izakovic, M. and Mazur, M. (2006) Free Radicals, Metals and Antioxidants in Oxidative Stress-Induced Cancer. Chemico-Biological Interactions, 160, 1-40.
https://doi.org/10.1016/j.cbi.2005.12.009
|
[9]
|
Falstie-Jensen, A.M., Kjærsgaard, A., Lorenzen, E.L., Jensen, J.D., Reinertsen, K.V., Dekkers, O.M., Ewertz, M. and Cronin-Fenton, D.P. (2019) Hypothyroidism and the Risk of Breast Cancer Recurrence and All-Cause Mortality—A Danish Population-Based Study. Breast Cancer Research, 21, Article No. 44.
https://doi.org/10.1186/s13058-019-1122-3
|
[10]
|
刘洁, 高静, 柏丁兮, 等. 甲状腺功能减退与乳腺癌发病风险关系Meta分析[J]. 中华肿瘤防治杂志, 2018, 25(13): 911-916.
|
[11]
|
Pan, X.-F., Ma, Y.-J., Tang, Y., Yu, M.-M., Wang, H. and Fan, Y.-R. (2020) Breast Cancer Populations May Have an Increased Prevalence of Thyroglobulin Anti-body and Thyroid Peroxidase Antibody: A Systematic Review and Meta-Analysis. Breast Cancer, 27, 828-836. https://doi.org/10.1007/s12282-020-01078-z
|
[12]
|
Baldini, E., Lauro, A., Tripodi, D., Pironi, D., Amabile, M.I., Ferent, I.C., Lori, E., Gagliardi, F., Bellini, M.I., Forte, F., Pacini, P., Cantisani, V., D’Andrea, V., Sorrenti, S. and Ulisse, S. (2022) Thyroid Diseases and Breast Cancer. Journal of Personalized Medicine, 12, Article No. 156. https://doi.org/10.3390/jpm12020156
|
[13]
|
Hu, X., Wang, X., Liang, Y., Chen, X., Zhou, S., Fei, W., Yang, Y. and Que, H. (2022) Cancer Risk in Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis. Frontiers in Endo-crinology, 13, Article 937871.
https://doi.org/10.3389/fendo.2022.937871
|
[14]
|
Giani, C., Fierabracci, P., Bonacci, R., Gigliotti, A., Campani, D., De Negri, F., Cecchetti, D., Martino, E. and Pinchera, A. (1996) Relationship between Breast Cancer and Thyroid Dis-ease: Relevance of Autoimmune Thyroid Disorders in Breast Malignancy. The Journal of Clinical Endocrinology & Me-tabolism, 81, 990-994.
https://doi.org/10.1210/jcem.81.3.8772562
|
[15]
|
Dhingra, M., Mahalanobis, S. and Das, A. (2022) Thyroid Recep-tor β Might Be Responsible for Breast Cancer Associated with Hashimoto’s Thyroiditis: A New Insight into Pathogene-sis. Immunologic Research, 70, 441-448.
https://doi.org/10.1007/s12026-022-09288-7
|
[16]
|
Özmen, T., Güllüoğlu, B.M., Yegen, C.Ş. and Soran, A. (2015) Autoimmune Thyroid Disease and Breast Cancer Prognosis. European Journal of Breast Health, 11, 67-71. https://doi.org/10.5152/tjbh.2015.2462
|
[17]
|
Brandt, J., Borgquist, S. and Manjer, J. (2015) Prospectively Measured Thyroid Hormones and Thyroid Peroxidase Antibodies in Relation to Risk of Different Breast Cancer Subgroups: A Malmö Diet and Cancer Study. Cancer Causes & Control, 26, 1093-1104. https://doi.org/10.1007/s10552-015-0602-8
|
[18]
|
Godlewska, M., Arczewska, K.D., Rudzińska, M., Łyczkowska, A., Krasuska, W., Hanusek, K., Ruf, J., Kiedrowski, M. and Czarnocka, B. (2017) Thyroid Peroxidase (TPO) Expressed in Thyroid and Breast Tissues Shows Similar Antigenic Properties. PLOS ONE, 12, e0179066. https://doi.org/10.1371/journal.pone.0179066
|
[19]
|
Siriwardhane, T., Krishna, K., Ranganathan, V., Jayaraman, V., Wang, T., Bei, K., Ashman, S., Rajasekaran, K., Rajasekaran, J.J. and Krishnamurthy, H. (2019) Significance of An-ti-TPO as an Early Predictive Marker in Thyroid Disease. Autoimmune Diseases, 2019, Article ID: 1684074. https://doi.org/10.1155/2019/1684074
|
[20]
|
Zhang, L., Wu, Y., Liu, F., Fu, L. and Tong, Z. (2016) Characteristics and Survival of Patients with Metachronous or Synchronous Double Primary Malignancies: Breast and Thyroid Cancer. Oncotarget, 7, 52450-52459.
https://doi.org/10.18632/oncotarget.9547
|
[21]
|
Huang, N.-S., Chen, X.-X., Wei, W.-J., Mo, M., Chen, J.-Y., Ma, B., Yang, S.-W., Xu, W.-B., Wu, J., Ji, Q.-H., Guo, X.-M., Liu, G.-Y., Shao, Z.-M. and Wang, Y. (2018) Association Between Breast Cancer and Thyroid Cancer: A Study Based on 13 978 Patients with Breast Cancer. Cancer Medicine, 7, 6393-6400. https://doi.org/10.1002/cam4.1856
|
[22]
|
Joseph, K.R., Edirimanne, S. and Eslick, G.D. (2015) The Association between Breast Cancer and Thyroid Cancer: A Meta-Analysis. Breast Cancer Research and Treatment, 152, 173-181. https://doi.org/10.1007/s10549-015-3456-6
|
[23]
|
Halada, S., Casado-Medrano, V., Baran, J.A., Lee, J., Chinmay, P., Bauer, A.J. and Franco, A.T. (2022) Hormonal Crosstalk between Thyroid and Breast Cancer. Endocri-nology, 163, Article ID: Bqac075.
https://doi.org/10.1210/endocr/bqac075
|
[24]
|
Block, G.E., Jensen, E.V. and Polley, T.Z. (1975) The Prediction of Hormonal Dependency of Mammary Cancer. Annals of Surgery, 182, 342-352. https://doi.org/10.1097/00000658-197509000-00017
|
[25]
|
Bolf, E.L., Sprague, B.L. and Carr, F.E. (2019) A Link-age between Thyroid and Breast Cancer: A Common Etiology? Cancer Epidemiology, Biomarkers & Prevention, 28, 643-649. https://doi.org/10.1158/1055-9965.EPI-18-0877
|
[26]
|
An, J.H., Hwangbo, Y., Ahn, H.Y., Keam, B., Lee, K.E., Han, W., Park, D.J., Park, I.A., Noh, D.Y., Youn, Y.K., Cho, B.Y., Im, S.A. and Park, Y.J. (2015) A Possible Association between Thyroid Cancer and Breast Cancer. Thyroid, 25, 1330-1338. https://doi.org/10.1089/thy.2014.0561
|
[27]
|
Pinheiro, M., Drigo, S.A., Tonhosolo, R., Andrade, S.C.S., Marchi, F.A., Jurisica, I., Kowalski, L.P., Achatz, M.I. and Rogatto, S.R. (2017) HABP2 p.G534E Variant in Patients with Fam-ily History of Thyroid and Breast Cancer. Oncotarget, 8, 40896-40905. https://doi.org/10.18632/oncotarget.16639
|
[28]
|
Tomsic, J., Fultz, R., Liyanarachchi, S., He, H., Senter, L. and de la Chapelle, A. (2016) HABP2 G534E Variant in Papillary Thyroid Carcinoma. PLOS ONE, 11, e0146315. https://doi.org/10.1371/journal.pone.0146315
|
[29]
|
Yang, S.P. and Ngeow, J. (2016) Familial Non-Medullary Thyroid Cancer: Unraveling the Genetic Maze. Endocrine-Related Cancer, 23, R577-R595. https://doi.org/10.1530/ERC-16-0067
|
[30]
|
Oh, J.M. and Ahn, B.C. (2021) Molecular Mechanisms of Radioactive Iodine Refractoriness in Differentiated Thyroid Cancer: Impaired Sodium Iodide Symporter (NIS) Expression Owing to Altered Signaling Pathway Activity and Intracellular Localization of NIS. Theranostics, 11, 6251-6277. https://doi.org/10.7150/thno.57689
|
[31]
|
Muller, I. and Barrett-Lee, P.J. (2020) The Antigenic Link between Thy-roid Autoimmunity and Breast Cancer. Seminars in Cancer Biology, 64, 122-134. https://doi.org/10.1016/j.semcancer.2019.05.013
|
[32]
|
Smyth, P.P. (2016) The Thyroid and Breast Cancer. Current Opinion in Endocrinology & Diabetes and Obesity, 23, 389-393. https://doi.org/10.1097/MED.0000000000000273
|
[33]
|
Muller, I., Zhang, L., Giani, C., Dayan, C.M., Ludgate, M.E. and Grennan-Jones, F. (2016) The Sodium Iodide Symporter Is Unlikely to Be a Thyroid/Breast Shared Antigen. Journal of Endocrinological Investigation, 39, 323-331.
https://doi.org/10.1007/s40618-015-0368-6s
|